-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
USDBörse Nasdaq
Mitarbeiter
87
Atai Life Sciences N.V. underperformed den DAX um -16 % vom 18.06.2021 bis 13.09.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von
Dir gefallen die Informationen zu Atai Life Sciences N.V.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Atai Life Sciences N.V.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Atai Life Sciences N.V.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Atai Life Sciences N.V.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
23 News & Informationen zur Atai Life Sciences N.V. Aktie
atai Life Sciences gets two new buy ratings on potential of psychedelics (NASDAQ:ATAI)
atai Life Sciences (ATAI) added ~5.6% in the pre-market after the German pharma company focused on psychedelics for mental disorders attracted two new buy ratings.
Pre-market Movers: FCUV, BXRX, LAIX, VALN…
The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 5.45 A.M. EDT)..
Newtyn Management, LLC Buys Stamps.com Inc, MBIA Inc, Garrett Motion Inc, Sells Ballys Corp, Golar LNG, CorePoint Lodging Inc
GuruFocus Article or News written by insider and the topic is about:
Where ATAI Life Sciences Stands With Analysts
ATAI Life Sciences (NASDAQ:ATAI) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3…
The Best and Worst New Stocks in 2021
New stocks came in droves this year, with a record number of IPOs priced. Now, we show you which new stocks are buys and which ones to avoid at all cost.
Pura Vida Investments, Llc Buys ATAI Life Sciences NV, Apria Inc, Agilon Health Inc, Sells , Vericel Corp, Align Technology Inc
GuruFocus Article or News written by insider and the topic is about:
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc. (NYSE: BIO) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) Gilead Sciences, Inc. (NASDAQ: GILD) GlaxoSmithKline plc (NYSE: GSK) Johnson & Johnson (NYSE: JNJ) Laboratory Corporation of America Holdings (NYSE: LH) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) NanoVibronix, Inc. (NASDAQ: NAOV) (announced intention to enter over-
Atai Life Sciences N.V. (ATAI) CEO Florian Brand on Q2 2021 Results – Earnings Call Transcript
Atai Life Sciences N.V. (NASDAQ:ATAI) Q2 2021 Earnings Conference Call August 16, 2021 08:30 ET Company Participants Greg Weaver – Chief Financial Officer Florian Brand – Chief Executive…
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Au…
Atai Life Sciences To Research Potent Psychedelic Herb Salvia Divinorum Through Its New Subsidiary – ATA (ATAI)
Atai Life Sciences (NASDAQ:ATAI) has announced the launch …
Atai Life Sciences To Host Conference Call And Webcast To Discuss Second Quarter 2021 Financial Results And Provide Business Update
BERLIN, Aug. 09, 2021 (GLOBE NEWSWIRE) — atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the
Atai Life Sciences To Present At The 41st Annual Canaccord Genuity Growth Conference
BERLIN, Aug. 06, 2021 (GLOBE NEWSWIRE) — atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the
Psychedelics Market Update: H1 2021 in Review
What happened in the psychedelics space in H1 2021? This psychedelics market update covers key trends to watch in this developing space.
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning session, 77 companies made new 52-week lows.
Areas of Interest: The largest company in terms of market cap to …
What to know about the booming psychedelics industry, where companies are racing to turn magic mushrooms and MDMA into approved medicines
Startups focused on turning psychedelic compounds into approved medicines have raised hundreds of millions of dollars.
Psychedelics Research FYI: Every Clinical Trial Underway Right Now Involving Public And Private Companies – ATA (ATAI), Clarmin Explorations (CLXPF), COMP SERVICES (CMPS), Entheon Biomedical (ENTBF),
This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Ps…
Aktien 2021 Empfehlung – Meine Top 3
Welche Aktien 2021 ich für die Erweiterung meines ETF Depot ausgesucht habe, stelle ich euch in diesem Beitrag vor. Seid gespannt!
Brown University Buys Blue Owl Capital Inc, ATAI Life Sciences NV
GuruFocus Article or News written by insider and the topic is about:
Tilray's war chest
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and personalities driving the multibillion-dollar cannabis boom.
Ketamine Clinic Company Field Trip Health Debuts On Nasdaq
As the fifth company in the psychedelic space to list on the Nasdaq, Field Trip Health aims to scale its drug-assisted therapy platform across North America with 75 clinics and eventually offer MDMA and psilocybin.
Top psychedelics VCs predict a tech boom and a rise of clinics over the next year
Psychedelics VCs told Insider that as the industry matures, they expect more ancillary businesses, like those focused on tech and clinics, to rise up.
Psychedelic trips could soon be part of therapy — here’s what those sessions will look like
In as soon as two years, tripping on mind-altering drugs like MDMA and psilocybin could become a regular part of therapy to treat conditions from depression to post-traumatic stress disorder.
Field Trip Health Heads To The Nasdaq As Wall Street Opens Up To “Psychedelics Renaissance”
Excitement around psychedelics grows as major U.S. exchanges make room for more companies in the sector. On Friday, Field Trip Health Ltd. (TSX:F…